# Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

> **NCT03097783** · NA · COMPLETED · sponsor: **Galderma R&D** · enrollment: 169 (actual)

## Conditions studied

- Midface Volume Deficit

## Interventions

- **DEVICE:** Restylane Perlane Lidocaine

## Key facts

- **NCT ID:** NCT03097783
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-26
- **Primary completion:** 2018-03-23
- **Final completion:** 2018-09-14
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03097783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03097783, "Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03097783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*